Tidal Investments LLC Purchases New Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Tidal Investments LLC bought a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,205 shares of the medical instruments supplier's stock, valued at approximately $342,000.

Several other hedge funds and other institutional investors have also made changes to their positions in ICUI. Harvest Fund Management Co. Ltd acquired a new stake in shares of ICU Medical in the fourth quarter valued at about $33,000. Quarry LP lifted its stake in shares of ICU Medical by 764.3% in the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after purchasing an additional 214 shares during the period. Murphy & Mullick Capital Management Corp acquired a new stake in shares of ICU Medical in the fourth quarter valued at about $52,000. Venturi Wealth Management LLC lifted its stake in shares of ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after purchasing an additional 206 shares during the period. Finally, Russell Investments Group Ltd. lifted its stake in shares of ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 300 shares during the period. Hedge funds and other institutional investors own 96.10% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently commented on ICUI shares. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Wall Street Zen upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. Raymond James cut their target price on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research report on Friday, May 9th. Finally, KeyCorp cut their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $192.67.

ICU Medical Trading Up 0.6%

ICU Medical stock traded up $0.82 during trading on Wednesday, reaching $131.36. The company had a trading volume of 262,024 shares, compared to its average volume of 277,871. ICU Medical, Inc. has a 12-month low of $105.30 and a 12-month high of $196.26. The stock's 50 day moving average price is $137.06 and its two-hundred day moving average price is $150.27. The firm has a market capitalization of $3.23 billion, a price-to-earnings ratio of -28.74 and a beta of 0.87. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The firm had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. During the same period in the previous year, the firm earned $0.96 earnings per share. ICU Medical's revenue was up 6.7% compared to the same quarter last year. As a group, equities analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Insider Activity at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 4,985 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total transaction of $640,572.50. Following the completion of the sale, the chief operating officer now directly owns 6,088 shares in the company, valued at $782,308. The trade was a 45.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Elisha W. Finney sold 600 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $138.92, for a total transaction of $83,352.00. Following the sale, the director now owns 3,252 shares of the company's stock, valued at approximately $451,767.84. This represents a 15.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 36,097 shares of company stock worth $4,860,156. 1.50% of the stock is owned by company insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.